NCT02718846

Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets

A Multicenter, Randomized, Open-label Clinical Study With a Concurrent Control Group to Assess the Effectiveness and Safety of Combined Therapy With Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets for Patients With Meniere's Disease

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 220 (actual)
• Sponsor: Alvogen Korea · Industry
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

A multicenter, randomized, open-label clinical study with a concurrent control group to assess the effectiveness and safety of combined therapy with Isobide solution and Meniace tablets compared to monotherapy with Meniace tablets for patients with Meniere's disease

Conditions

• Meniere's Disease

Interventions

Type	Name	Description
DRUG	Meniace	6 mg of Meniace tablets were administered 3 times per day after meals
DRUG	Isobide	an initial dosage of 90 mL of Isobide solution was administered orally 3 times a day after meals

Timeline

• Start date: 2013-02-01
• Primary completion: 2015-05-01
• Completion: 2015-05-01
• First posted: 2016-03-24
• Last updated: 2016-03-24